Clinical Trials Browser

Phase 2 × Ovarian Neoplasms × Ramucirumab × Clear all

NCT00721162 2019-09-26

Study of Ramucirumab in Ovarian Cancer

Phase 2 Completed

60 enrolled 14 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms